Recent years have witnessed the emergence of a considerable amount of data pertaining to the application of bone marrow mesenchymal stem cells (MSCs) in promoting angiogenesis in the field of regenerative medicine. Nevertheless, some authors have provided evidence that MSCs can also prevent the process of angiogenesis, which is desirable in certain pathologies such as tumor growth. Plenty of in vitro and in vivo research studies have been undertaken to illuminate the underlying mechanisms by which MSCs promote or inhibit neo-angiogenesis. To date, both secretary capacity and differentiation into endothelial-like cells have been reported in MSC-based pro-angiogenic therapies. This review seeks to shed further light on interactions between MSCs and endothelial cells in different physiopathological conditions.
Get full access to this article
View all access options for this article.
References
1.
RahbarghaziR, NassiriSM, KhazraiiniaP, KajbafzadehAM, AhmadiSH, MohammadiE, MolazemM and Zamani-AhmadmahmudiM. (2013). Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev, 22:855–865.
2.
ChavakisE and DimmelerS. (2002). Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler Thromb Vasc Biol, 22:887–893.
3.
IAWHo, TohHC, NgWH, TeoYL, GuoCM, HuiKM and LamPYP. (2013). Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells, 31:146–155.
4.
PittengerMF, MackayAM, BeckSC, JaiswalRK, DouglasR, MoscaJD, MoormanMA, SimonettiDW, CraigS and MarshakDR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284:143–147.
5.
RüsterB, GöttigS, LudwigRJ, BistrianR, MüllerS, SeifriedE, GilleJ and HenschlerR. (2006). Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood, 108:3938–3944.
6.
Veevers-LoweJ, BallSG, ShuttleworthA and KieltyCM. (2011). Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals. J Cell Sci, 124:1288–1300.
7.
OswaldJ, BoxbergerS, JørgensenB, FeldmannS, EhningerG, BornhäuserM and WernerC. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22:377–384.
8.
SilvaGV, LitovskyS, AssadJAR, SousaALS, MartinBJ, VelaD, CoulterSC, LinJ, OberJ, et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111:150–156.
9.
DharK, DharG, MajumderM, HaqueI, MehtaS, Van VeldhuizenPJ, BanerjeeSK and BanerjeeS. (2010). Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1. Mol Cancer, 9:209–221.
10.
ChenL, TredgetEE, WuPYG and WuY. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 3:e1886.
11.
RafiiS and LydenD. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med, 9:702–712.
12.
FathkeC, WilsonL, HutterJ, KapoorV, SmithA, HockingA and IsikF. (2004). Contribution of bone marrow–derived cells to skin: collagen deposition and wound repair. Stem Cells, 22:812–822.
13.
OtsuK, DasS, HouserSD, QuadriSK, BhattacharyaS and BhattacharyaJ. (2009). Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood, 113:4197–4205.
14.
OhJY, KimMK, ShinMS, LeeHJ, KoJH, WeeWR and LeeJH. (2008). The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells, 26:1047–1055.
15.
TeoGSL, AnkrumJA, MartinelliR, BoettoSE, SimmsK, SciutoTE, DvorakAM, KarpJM and CarmanCV. (2012). Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells, 30:2472–2486.
16.
LeyK, LaudannaC, CybulskyMI and NoursharghS. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol, 7:678–689.
17.
KasperG, DankertN, TuischerJ, HoeftM, GaberT, GlaeserJD, ZanderD, TschirschmannM, ThompsonM, MatziolisG and DudaGN. (2007). Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells, 25:903–910.
18.
XueY, XingZ, HellemS, ArvidsonK and MustafaK. (2009). Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online, 8:34.
19.
SemonJ, NagyL, LlamasC, TuckerHA, LeeR and ProckopD. (2010). Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res, 341:147–158.
20.
SchneiderD and EngelmanDM. (2004). Involvement of transmembrane domain interactions in signal transduction by α/β Integrins. J Biol Chem, 279:9840–9846.
21.
TabeY, JinL, Tsutsumi-IshiiY, XuY, McQueenT, PriebeW, MillsGB, OhsakaA, NagaokaI, AndreeffM and KonoplevaM. (2007). Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow–derived stromal cells. Cancer Res, 67:684–694.
22.
TanC, Cruet-HennequartS, TroussardA, FazliL, CostelloP, SuttonK, WheelerJ, GleaveM, SangheraJ and DedharS. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 5:79–90.
23.
XieW, ZhaoM, ZhouW, GuoL, HuangL, YuW and LiX. (2013). Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells. Ophthalmic Res, 49:139–149.
24.
DochevaD, HaastersF and SchiekerM. (2008). Mesenchymal stem cells and their cell surface receptors. Curr Rheumatol Rev, 4:155–160.
25.
LiY, HiroiY and LiaoJK. (2010). Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med, 20:228–231.
26.
SegersVFM, Van RietI, AndriesLJ, LemmensK, DemolderMJ, De BeckerAJML, KockxMM and De KeulenaerGW. (2006). Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol, 290:H1370–H1377.
27.
IsobeM, YagitaH, OkumuraK and IharaA. (1992). Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science, 255:1125–1127.
28.
ChamberlainG, SmithH, RaingerGE and MiddletonJ. (2011). Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear. PLoS One, 6:e25663
29.
ZhuH, MitsuhashiN, KleinA, BarskyLW, WeinbergK, BarrML, DemetriouA and WuGD. (2006). The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells, 24:928–935.
30.
ZhaoW, LohW, DroujinineIA, TeoW, KumarN, SchaferS, CuiCH, ZhangL, SarkarD, KarnikR and KarpJM. (2011). Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. FASEB J, 25:3045–3056.
31.
SacksteinR, MerzabanJS, CainDW, DagiaNM, SpencerJA, LinCP and WohlgemuthR. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 14:181–187.
32.
PotapovaI, CohenI and DoroninS. (2010). Von willebrand factor increases endothelial cell adhesiveness for human mesenchymal stem cells by activating p38 mitogen-activated protein kinase. Stem Cell Res Ther, 1:35
33.
SteingenC, BrenigF, BaumgartnerL, SchmidtJ, SchmidtA and BlochW. (2008). Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol, 44:1072–1084.
34.
HaiderHK, JiangS, IdrisNM and AshrafM. (2008). IGF-1–overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair. Circ Res, 103:1300–1308.
35.
ZhangF, WangC, WangH, LuM, LiY, FengH, LinJ, YuanZ and WangX. (2013). Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression. Mediators Inflamm 2013:Article ID. 691023.
36.
SalemHK and ThiemermannC. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 28:585–596.
37.
LinderS. (2009). Invadosomes at a glance. J Cell Sci, 122:3009–3013.
38.
RingeJ, StrassburgS, NeumannK, EndresM, NotterM, BurmesterG-R, KapsC and SittingerM. (2007). Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem, 101:135–146.
39.
SmithH, WhittallC, WekslerB and MiddletonJ. (2011). Chemokines stimulate bidirectional migration of human mesenchymal stem cells across bone marrow endothelial cells. Stem Cells Dev, 21:476–486.
40.
JohanssonU, RasmussonI, NiclouSP, ForslundN, GustavssonL, NilssonB, KorsgrenO and MagnussonPU. (2008). Formation of composite endothelial cell–mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes, 57:2393–2401.
41.
LiN, LuX, ZhaoX, XiangF-L, XenocostasA, KarmazynM and FengQ. (2009). Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1α. Stem Cells, 27:961–970.
42.
AguirreA, PlanellJA and EngelE. (2010). Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun, 400:284–291.
43.
WangN, ZhangR, WangS-J, ZhangC-L, MaoL-B, ZhuangC-Y, TangY-Y, LuoX-G, ZhouH and ZhangT-C. (2013). Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/myocardin-related transcription factor-A signaling pathway. Int J Biochem Cell Biol, 45:1447–1456.
44.
BlockiA, WangY, KochM, PehP, BeyerS, LawP, HuiJ and RaghunathM. (2013). Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev, 22:2347–2355.
45.
ChongJJ, ReineckeH, IwataM, Torok-StorbB, Stempien-OteroA and MurryCE. (2013). Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev, 22:1932–1943.
46.
SchlosserS, DennlerC, SchweizerR, EberliD, SteinJV, EnzmannV, GiovanoliP, ErniD and PlockJA. (2012). Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc Res, 83:267–275.
47.
LinRZ, Moreno-LunaR, ZhouB, PuWT and Melero-MartinJM. (2012). Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis, 15:443–455.
48.
KalininaN, SysoevaVY, RubinaK, ParfenovaYV and TkachukV. (2011). Mesenchymal stem cells in tissue growth and repair. Acta Nat, 3:30–37.
49.
CaplanAI. (2008). All MSCs are pericytes?. Cell Stem Cell, 3:229–230.
50.
SalehFA, WhyteM, AshtonP and GeneverPG. (2010). Regulation of mesenchymal stem cell activity by endothelial cells. Stem Cells Dev, 20:391–403.
51.
BallSG, ShuttleworthAC and KieltyCM. (2004). Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol, 36:714–727.
52.
SalehFA, WhyteM and GeneverPG. (2011). Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater, 22:242–257.
53.
PatiS, GerberMH, MengeTD, WatahaKA, ZhaoY, BaumgartnerJA, ZhaoJ, LetourneauPA, HubyMP, et al. (2011). Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLoS One, 6:e25171
54.
PatiS, KhakooAY, ZhaoJ, JimenezF, GerberMH, HartingM, RedellJB, GrillR, MatsuoY, et al. (2011). Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev, 20:89–101.
55.
MengeT, GerberM, WatahaK, ReidW, GuhaS, CoxCSJr., DashP, ReitzMSJr., KhakooAY and PatiS. (2013). Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/beta-catenin signaling pathway. Stem Cells Dev, 22:148–157.
56.
StenmanJM, RajagopalJ, CarrollTJ, IshibashiM, McMahonJ and McMahonAP. (2008). Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science, 322:1247–1250.
57.
DufourcqP, DescampsB, TojaisNF, LerouxL, OsesP, DaretD, MoreauC, LamazièreJ-MD, CouffinhalC and DuplàaT. (2008). Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells, 26:2991–3001.
58.
AlfaroMP, PagniM, VincentA, AtkinsonJ, HillMF, CatesJ, DavidsonJM, RottmanJ, LeeE and YoungPP. (2008). The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci U S A, 105:18366–18371.
59.
DuffyGP, D'ArcyS, AhsanT, NeremRM, O'BrienT and BarryF. (2010). Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential. Tissue Eng Part A, 16:2755–2768.
60.
BidarraSJ, BarriasCC, BarbosaMA, SoaresR, AmédéeJ and GranjaPL. (2011). Phenotypic and proliferative modulation of human mesenchymal stem cells via crosstalk with endothelial cells. Stem Cell Res, 7:186–197.
61.
SorrellJM, BaberMA and CaplanAI. (2009). Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A, 15:1751–1761.
62.
JimenezE, VicenteA, SacedonR, MunozJJ, WeinmasterG, ZapataAG and VarasA. (2001). Distinct mechanisms contribute to generate and change the CD4:CD8 cell ratio during thymus development: a role for the Notch ligand, Jagged1. J Immunol, 166:5898–5908.
63.
ZacharekA, ChenJ, CuiX, LiA, LiY, RobertsC, FengY, GaoQ and ChoppM. (2007). Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab, 27:1684–1691.
64.
LiuXB, JiangJ, GuiC, HuXY, XiangMX and WangJA. (2008). Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol Sin, 29:815–822.
65.
BaraniakPR and McDevittTC. (2010). Stem cell paracrine actions and tissue regeneration. Regen Med, 5:121–143.
66.
ZhangH-C, LiuX-B, HuangS, BiX-Y, WangH-X, XieL-X, WangY-Q, CaoX-F, LvJ and XiaoF-J. (2012). Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev, 21:3289–3297.
67.
BaglioSR, PegtelDM and BaldiniN. (2012). Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol, 3:359
68.
KimH-S, ChoiD-Y, YunSJ, ChoiS-M, KangJW, JungJW, HwangD, KimKP and KimD-W. (2011). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res, 11:839–849.
69.
ChoiY-A, LimJ, KimKM, AcharyaB, ChoJ-Y, BaeY-C, ShinH-I, KimS-Y and ParkEK. (2010). Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res, 9:2946–2956.
70.
XinH, LiY, CuiY, YangJJ, ZhangZG and ChoppM. (2013). Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab, 33:1711–1715.
71.
XinH, LiY, LiuZ, WangX, ShangX, CuiY, Gang ZhangZ and ChoppM. (2013). Mir-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells [Epub ahead of print]; DOI:10.1002/stem.1409.
ZhuY-G, FengX-M, AbbottJ, FangX-H, HaoQ, MonselA, QuJ-M, MatthayMA and LeeJW. (2013). Human mesenchymal stem cell microvesicles for treatment of E. coli endotoxin-induced acute lung injury in mice. Stem Cells [Epub ahead of print]; DOI:10.1002/stem.1504.
74.
LiT, YanY, WangB, QianH, ZhangX, ShenL, WangM, ZhouY, ZhuW, LiW and XuW. (2013). Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev, 22:845–854.
75.
MaumusM, JorgensenC and NoelD. (2013). Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes. Biochimie, 95:2229–2234.
76.
KatakowskiM, BullerB, ZhengX, LuY, RogersT, OsobamiroO, ShuW, JiangF and ChoppM. (2013). Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett, 335:201–204.
KaiglerD, KrebsbachPH, PolveriniPJ and MooneyDJ. (2003). Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng, 9:95–103.
79.
BurlacuA, GrigorescuG, RoscaA-M, PredaMB and SimionescuM. (2012). Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev, 22:643–653.
80.
FindleyCM, CudmoreMJ, AhmedA and KontosCD. (2007). VEGF induces Tie2 shedding via a phosphoinositide 3-Kinase/Akt–dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol, 27:2619–2626.
81.
LerouxL, DescampsB, TojaisNF, SéguyB, OsesP, MoreauC, DaretD, IvanovicZ, BoironJ-M and LamazièreJ-MD. (2010). Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther, 18:1545–1552.
82.
ChangJ, SonoyamaW, WangZ, JinQ, ZhangC, KrebsbachPH, GiannobileW, ShiS and WangC-Y. (2007). Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem, 282:30938–30948.
83.
KasperG, GlaeserJD, GeisslerS, OdeA, TuischerJ, MatziolisG, PerkaC and DudaGN. (2007). Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior. Stem Cells, 25:1985–1994.
84.
GhajarCM, BlevinsKS, HughesCC, GeorgeSC and PutnamAJ. (2006). Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng, 12:2875–2888.
85.
PortalskaKJ, LeferinkA, GroenN, FernandesH, MoroniL, van BlitterswijkC and de BoerJ. (2012). Endothelial differentiation of mesenchymal stromal cells. PLoS One, 7:e46842
86.
NassiriSM, KhakiZ, SoleimaniM, AhmadiSH, JahanzadI, RabbaniS, SahebjamM, ArdalanFA and FathollahiMS. (2007). The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J Biomed Sci, 14:745–755.
87.
VittorioO, JacchettiE, PaciniS and CecchiniM. (2013). Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction. Integr Biol, 5:291–299.
88.
LionettiV, CecchiniM and VenturaC. (2010). Nanomechanics to drive stem cells in injured tissues: insights from current research and future perspectives. Stem Cells Dev, 20:561–568.
89.
PortalskaKJ, LeferinkA, GroenN, FernandesH, MoroniL, van BlitterswijkJ and de BoerC. (2012). Endothelial differentiation of mesenchymal stromal cells. PLoS One, 7:e46842
90.
KönigJ, HuppertzB, DesoyeG, ParoliniO, FröhlichJD, WeissG, DohrG, SedlmayrP and LangI. (2011). Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells. Stem Cells Dev, 21:1309–1320.
91.
DavaniS, MarandinA, MersinN, RoyerB, KantelipB, HervéP, EtieventJ-P and KantelipJ-P. (2003). Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation, 108:II-253––II-258.
92.
LeeM-Y, HuangJ-P, ChenY-Y, AplinJD, WuY-H, ChenC-Y, ChenP-C and ChenC-P. (2009). Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin α5β1. PLoS One, 4:e6913
93.
MayerH, BertramH, LindenmaierW, KorffT, WeberH and WeichH. (2005). Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: Autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem, 95:827–839.
94.
QiuX, SunC, YuW, LinH, SunZ, ChenY, WangR and DaiY. (2012). Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J Androl, 33:37–44.
95.
ShabbirA, ZisaD, SuzukiG and LeeT. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol, 296:H1888–H1897.
96.
BarkerTH. (2011). The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials, 32:4211–4214.
97.
WuC-C, ChaoY-C, ChenC-N, ChienS, ChenY-C, ChienC-C, ChiuJ-J, Linju YenB. (2008). Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells. J Biomech, 41:813–821.
98.
AuP, TamJ, FukumuraD and JainRK. (2008). Bone marrow–derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood, 111:4551–4558.
99.
CarrionB, HuangCP, GhajarCM, KachgalS, KniazevaE, JeonNL and PutnamAJ. (2010). Recreating the perivascular niche ex vivo using a microfluidic approach. Biotechnol Bioeng, 107:1020–1028.
100.
ZhouJ, ChengM, LiaoY-H, HuY, WuM, WangQ, QinB, WangH, ZhuY, et al. (2013). Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells. PLoS One, 8:e63126
101.
OhtaniK, VlachojannisGJ, KoyanagiM, BoeckelJ-N, UrbichC, FarcasR, BonigH, MarquezVE, ZeiherAM and DimmelerS. (2011). Epigenetic regulation of endothelial lineage committed genes in pro-Angiogenic hematopoietic and endothelial progenitor cells. Circ Res, 109:1219–1229.
102.
GomesSA, RangelEB, PremerC, DulceRA, CaoY, FloreaV, BalkanW, RodriguesCO, SchallyAV and HareJM. (2013). S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc Natl Acad Sci U S A, 110:2834–2839.
103.
AhmedRPH, HaiderKH, ShujiaJ, AfzalMR and AshrafM. (2010). Sonic hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/Netrin-1/PKC pathway. PLoS One, 5:e8576
104.
OcarinoNM, BoeloniJN, GoesAM, SilvaJF, MarubayashiU and SerakidesR. (2008). Osteogenic differentiation of mesenchymal stem cells from osteopenic rats subjected to physical activity with and without nitric oxide synthase inhibition. Nitric Oxide, 19:320–325.
105.
BirminghamE, NieburG, McHughP, ShawG, BarryF and McNamaraL. (2012). Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater, 23:13–27.
106.
TassoR, UliviV, ReverberiD, Lo SiccoC, DescalziF and CanceddaR. (2013). In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. Stem Cells Dev [Epub ahead of print]; DOI:10.1089/scd.2013.0313
107.
KurpinskiK, LamH, ChuJ, WangA, KimA, TsayE, AgrawalS, SchafferDV and LiS. (2010). Transforming growth factor-β and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells, 28:734–742.
108.
BoopathyAV, PendergrassKD, ChePL, YoonY-S and DavisME. (2013). Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res Ther, 4:43
109.
LeeRH, YoonN, ReneauJC and ProckopDJ. (2012). Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity. Cell Stem Cell, 11:825–835.
110.
SecchieroP, ZorzetS, TripodoC, CoralliniF, MelloniE, CarusoL, BoscoR, IngraoS, ZavanB and ZauliG. (2010). Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One, 5:e11140
111.
GomesCM. (2013). The dual role of mesenchymal stem cells in tumor progression. Stem Cell Res Ther, 4:42
112.
DvorakHF. (2003). How tumors make bad blood vessels and stroma. Am J Pathol, 162:1747–1757.
113.
ZhangZ, NeivaKG, LingenMW, EllisLM and NörJE. (2009). VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ, 17:499–512.
114.
KerbelRS. (2008). Tumor angiogenesis. N Engl J Med, 358:2039–2049.
115.
WelsJ, KaplanRN, RafiiS and LydenD. (2008). Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev, 22:559–574.
116.
DingW, KnoxTR, TschumperRC, WuW, SchwagerSM, BoysenJC, JelinekDF and KayNE. (2010). Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood, 116:2984–2993.
117.
MenonLG, PicinichS, KoneruR, GaoH, LinSY, KoneruM, Mayer-KuckukP, GlodJ and BanerjeeD. (2007). Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells orbone marrow cells. Stem Cells, 25:520–528.
118.
HuangW, ChangM, TsaiK, HungM, ChenH and HungS. (2012). Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene, 32:4343–4345.
119.
BurnsJS, KristiansenM, KristensenLP, LarsenKH, NielsenMO, ChristiansenH, NehlinJ, AndersenJS and KassemM. (2011). Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction. PLoS One, 6:e21888
120.
ZhangT, LeeYW, RuiYF, ChengTY, JiangXH and LiG. (2013). Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther, 4:70
121.
Proulx-BonneauS, GuezguezA and AnnabiB. (2011). A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells. PLoS One, 6:e21511
122.
WangX, ZhangZ and YaoC. (2010). Angiogenic activity of mesenchymal stem cells in multiple myeloma. Cancer Invest, 29:37–41.
123.
FouraschenSM, PanQ, de RuiterPE, FaridWR, KazemierG, KwekkeboomJ, IjzermansJN, MetselaarHJ, TilanusJ and de JongeHW. (2012). Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev, 21:2410–2419.
124.
GruberR, KandlerB, HolzmannP, Vögele-KadletzM, LosertU, FischerMB and WatzekG. (2005). Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng, 11:896–903.
125.
AnnabiB, NaudE, LeeY-T, EliopoulosN and GalipeauJ. (2004). Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem, 91:1146–1158.
126.
SunB, ZhangS, NiC, ZhangD, LiuY, ZhangW, ZhaoX, ZhaoC and ShiM. (2005). Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. Stem Cells Dev, 14:292–298.
127.
SuzukiK, SunR, OriguchiM, KanehiraM, TakahataT, ItohJ, UmezawaA, KijimaH, FukudaS and SaijoY. (2011). Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med, 17:579–587.
128.
LiuY, HanZP, ZhangSS, JingYY, BuXX, WangCY, SunK, JiangGC, ZhaoX, et al. (2011). Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem, 286:25007–25015.
129.
ZhuW, HuangL, LiY, ZhangX, GuJ, YanY, XuX, WangM, QianH and XuW. (2012). Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett, 315:28–37.
QuanteM, TuS, TomitaH, GondaT, WangS, TakashiS, BaikG, ShibataW, DipreteB, et al. (2011). Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell, 19:257–272.
132.
MiZ, BhattacharyaSD, KimVM, GuoH, TalbotLJ and KuoPC. (2011). Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis, 32:477–487.
PaunescuV, BojinFM, TatuCA, GavriliucOI, RoscaA, GruiaAT, TanasieG, BunuC, CrisnicD, et al. (2011). Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med, 15:635–646.
135.
CalabreseC, PoppletonH, KocakM, HoggTL, FullerC, HamnerB, OhEY, GaberMW, FinklesteinD and AllenM. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell, 11:69–82.
136.
CharlesN, OzawaT, SquatritoM, BleauA-M, BrennanCW, HambardzumyanD and HollandEC. (2010). Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell, 6:141–152.
137.
BorovskiT, De SousaE, MeloF, VermeulenL and MedemaJP. (2011). Cancer stem cell niche: the place to be. Cancer Res, 71:634–639.
138.
OrimoA, GuptaPB, SgroiDC, Arenzana-SeisdedosF, DelaunayT, NaeemR, CareyVJ, RichardsonAL and WeinbergRA. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121:335–348.
139.
BagleyRG, WeberW, RouleauC, YaoM, HonmaN, KataokaS, IshidaI, RobertsBL and TeicherBA. (2009). Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol, 34:619–627.
140.
KucerovaL and SkolekovaS. (2013). Tumor microenvironment and the role of mesenchymal stromal cells. Neoplasma, 60:1–10.
141.
ShinagawaK, KitadaiY, TanakaM, SumidaT, OnoyamaM, OhnishiM, OharaE, HigashiY, TanakaS, YasuiW and ChayamaK. (2013). Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int J Cancer, 132:813–823.
142.
PotentaS, ZeisbergE and KalluriR. (2008). The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer, 99:1375–1379.
143.
GhaediM, SoleimaniM, TaghvaieNM, SheikhfatollahiM, AzadmaneshK, LotfiAS and WuJ. (2011). Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors. J Gene Med, 13:171–180.
144.
KloppAH, GuptaA, SpaethE, AndreeffM and MariniF. (2011). Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells, 29:11–19.
145.
RamasamyR, LamEW, SoeiroI, TisatoV, BonnetD and DazziF. (2007). Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia, 21:304–310.
146.
VillarsF, GuillotinB, AmedeeT, DutoyaS, BordenaveL, BareilleR and AmedeeJ. (2002). Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol, 282:C775–C785.
